Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med, 2011
A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet, 2011
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study Lancet, 2011
Wormser D…[195 co-authors]…Danesh J. Separate and combined associations of body- mass index and abdominal adiposity with cardiovascular disease. Lancet 2011;377:1085-95.
Sarwar N…[251 co-authors]…Danesh J. Triglyceride-mediated pathways and coronary disease. Lancet 2010;375:1634-9.
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet, 2010
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet, 2010
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 2010
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA, 2009
Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 2009
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA, 2008
Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA, 2007
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA, 2005
Antibiotics in the prevention of heart attacks. Lancet, 2005
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 2004
Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies. Lancet, 2004